American Society of Hematology

ASH President: Immigration Decision Disappointing

Published on: June 27, 2018

(WASHINGTON, June 27, 2018) — Yesterday, the Supreme Court of the United States upheld President Trump’s authority to restrict immigration from seven countries. The American Society of Hematology (ASH) has opposed every iteration of this policy1, 2 and previously joined the Association of American Medical Colleges and 33 other health care organizations in filing an amicus brief urging the Court to reinstate a nationwide injunction against it.

ASH President Alexis A. Thompson, MD, MPH, of the Ann and Robert H. Lurie Children’s Hospital of Chicago, responded to the Court’s ruling:

“Yesterday’s ruling by the Supreme Court is disappointing. Every year, talented medical professionals come to the United States to learn, collaborate, and advance the fields of science, health, and medicine. ASH recognizes the contributions of all scientists and caregivers, regardless of national origin, and will work with lawmakers on Capitol Hill to find legislative solutions that keep our borders strong while ensuring the United States attracts the strongest possible biomedical research workforce from around the globe.”


The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online. In 2016, ASH launched Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal.

Contact:
Stephen Fitzmaurice, American Society of Hematology
sfitzmaurice@hematology.org; 202-552-4927

back to top